Literature DB >> 21441024

Discovery of the first non-ATP competitive IGF-1R kinase inhibitors: advantages in comparison with competitive inhibitors.

Dominique Lesuisse1, Jacques Mauger, Conception Nemecek, Sébastien Maignan, Janine Boiziau, Greg Harlow, Augustin Hittinger, Swen Ruf, Hartmut Strobel, Anil Nair, Kurt Ritter, Jean-Luc Malleron, Anne Dagallier, Youssef El-Ahmad, Jean-Pierre Guilloteau, Houlfa Guizani, Hervé Bouchard, Corinne Venot.   

Abstract

A new series of IGF-1R inhibitors related to hydantoins were identified from a lead originating from HTS. Their noncompetitive property as well as their slow binding characteristics provided a series of compounds with unique selectivity and excellent cellular activities.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21441024     DOI: 10.1016/j.bmcl.2011.03.003

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  4 in total

1.  Slow inhibition and conformation selective properties of extracellular signal-regulated kinase 1 and 2 inhibitors.

Authors:  Johannes Rudolph; Yao Xiao; Arthur Pardi; Natalie G Ahn
Journal:  Biochemistry       Date:  2014-12-04       Impact factor: 3.162

2.  Effective natural inhibitors targeting IGF-1R by computational study.

Authors:  Xinyu Wang; Pengcheng Zhou; Liangxin Lin; Bo Wu; Zhaoyu Fu; Xing Huang; Dong Zhu
Journal:  Aging (Albany NY)       Date:  2022-06-09       Impact factor: 5.955

3.  A highly selective dual insulin receptor (IR)/insulin-like growth factor 1 receptor (IGF-1R) inhibitor derived from an extracellular signal-regulated kinase (ERK) inhibitor.

Authors:  Theonie Anastassiadis; Krisna C Duong-Ly; Sean W Deacon; Alec Lafontant; Haiching Ma; Karthik Devarajan; Roland L Dunbrack; Jinhua Wu; Jeffrey R Peterson
Journal:  J Biol Chem       Date:  2013-08-09       Impact factor: 5.157

4.  AMP-activated protein kinase selectively inhibited by the type II inhibitor SBI-0206965.

Authors:  Toby A Dite; Christopher G Langendorf; Ashfaqul Hoque; Sandra Galic; Richard J Rebello; Ashley J Ovens; Lisa M Lindqvist; Kevin R W Ngoei; Naomi X Y Ling; Luc Furic; Bruce E Kemp; John W Scott; Jonathan S Oakhill
Journal:  J Biol Chem       Date:  2018-04-25       Impact factor: 5.157

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.